Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Hepatology. 2024 Jul 1;80(1):119-135. doi: 10.1097/HEP.0000000000000675. Epub 2023 Nov 9.
Alcohol-associated liver disease is a major cause of alcohol-associated mortality. Recently, we identified hepatic demethylases lysine demethylase (KDM)5B and KDM5C as important epigenetic regulators of alcohol response in the liver. In this study, we aimed to investigate the role of KDM5 demethylases in alcohol-associated liver disease resolution.
We showed that alcohol-induced liver steatosis rapidly resolved after alcohol cessation. In contrast, fibrosis persisted in the liver for up to 8 weeks after the end of alcohol exposure. Defects in fibrosis resolution were in part due to alcohol-induced KDM5B and KDM5C-dependent epigenetic changes in hepatocytes. Using cell-type-specific knockout mice, we found that adeno-associated virus-mediated knockout of KDM5B and KDM5C demethylases in hepatocytes at the time of alcohol withdrawal promoted fibrosis resolution. Single-cell ATAC sequencing analysis showed that during alcohol-associated liver disease resolution epigenetic cell states largely reverted to control conditions. In addition, we found unique epigenetic cell states distinct from both control and alcohol states and identified associated transcriptional regulators, including liver X receptor (LXR) alpha (α). In vitro and in vivo analysis confirmed that knockout of KDM5B and KDM5C demethylases promoted LXRα activity, likely through regulation of oxysterol biosynthesis, and this activity was critical for the fibrosis resolution process. Reduced LXR activity by small molecule inhibitors prevented fibrosis resolution in KDM5-deficient mice.
In summary, KDM5B and KDM5C demethylases prevent liver fibrosis resolution after alcohol cessation in part through suppression of LXR activity.
酒精相关性肝病是导致与酒精相关死亡的主要原因。最近,我们发现组蛋白赖氨酸去甲基酶(KDM)5B 和 KDM5C 是肝脏中酒精反应的重要表观遗传调控因子。在这项研究中,我们旨在研究 KDM5 去甲基酶在酒精相关性肝病消退中的作用。
我们表明,酒精戒断后,肝脏脂肪变性迅速消退。相比之下,纤维化在酒精暴露结束后长达 8 周内仍持续存在。纤维化消退缺陷部分归因于酒精诱导的 KDM5B 和 KDM5C 依赖的肝细胞核内体去甲基化酶在肝细胞中的表观遗传变化。使用细胞类型特异性敲除小鼠,我们发现,在酒精戒断时,腺相关病毒介导的肝细胞 KDM5B 和 KDM5C 去甲基酶敲除促进了纤维化消退。单细胞 ATAC 测序分析表明,在酒精相关性肝病消退过程中,表观遗传细胞状态在很大程度上恢复到对照条件。此外,我们发现了独特的表观遗传细胞状态,与对照和酒精状态均不同,并鉴定出相关的转录调控因子,包括肝 X 受体(LXR)α(α)。体外和体内分析证实,敲除 KDM5B 和 KDM5C 去甲基酶可促进 LXRα活性,可能通过调节氧化固醇生物合成,而这种活性对于纤维化消退过程至关重要。小分子抑制剂降低 LXR 活性可阻止 KDM5 缺陷小鼠的纤维化消退。
总之,KDM5B 和 KDM5C 去甲基酶通过抑制 LXR 活性部分阻止了酒精戒断后肝脏纤维化的消退。